Thomson Reuters
TRI
99.28
+1.19
+1.21%
Thomson Reuters
US · TRI
#530 by market cap
Listed 1970
99.28
+1.19
+1.21%
Live - 5344 symbols - heartbeat 63s ago
· 2026-10-08 04:00
Pre-market
99.28
0.00%
After-hours
99.28
0.00%
Overnight
99.28
0.00%
- Market cap
- 43.01B
- P/E (TTM)i
- 26.25
- P/Bi
- 3.87
- EPSi
- 3.38
- Div yieldi
- 2.55%
- 52W posi
- 29%
Reader sentiment
Are you bullish or bearish on TRI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.70, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.00% YoY
Margins
- Gross margin
- 75.80%
- Operating margin
- 26.61%
- Net margin
- 20.04%
Key ratios & quality
- Enterprise valuei
- 44.73B
- PEG ratioi
- 6.68
- Altman Z-Scorei
- 5.70
PEG uses trailing P/E against the 3-year net income growth rate (3.93%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.50B | 5.91B | 5.98B | 6.35B | 6.63B | 6.79B | 7.26B | 7.48B |
| Gross profit | 4.22B | 4.23B | 4.55B | 4.77B | 5.04B | 5.23B | 5.47B | 5.67B |
| Selling & admin expenses | 2.74B | 2.67B | 2.52B | 2.75B | 2.67B | 2.53B | 2.66B | 2.72B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 775.00M | 1.20B | 1.92B | 1.23B | 1.82B | 1.95B | 1.90B | 1.99B |
| Pretax profit | 533.00M | 971.00M | 1.76B | 1.05B | 2.08B | 1.99B | 2.03B | 1.93B |
| Tax | 136.00M | -1.20B | 71.00M | 1.61B | 259.00M | 417.00M | -123.00M | 423.00M |
| Net profit | 4.02B | 1.56B | 1.12B | 5.69B | 1.34B | 2.70B | 2.21B | 1.50B |
| Basic EPS | 6 | 3 | 2 | 12 | 3 | 6 | 5 | 3 |
| Diluted EPS | 6.20 | 3.28 | 2.37 | 12.12 | 2.90 | 5.89 | 4.97 | 3.38 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.90B | 1.79B | 1.78B | 2.01B | 2.09B | 1.95B |
| Gross profit | 1.45B | 1.35B | 1.35B | 1.52B | 1.59B | 1.47B |
| Selling & admin expenses | 644.00M | 670.00M | 674.00M | 729.00M | 704.00M | 713.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 570.00M | 443.00M | 598.00M | 378.00M | 636.00M | 560.00M |
| Pretax profit | 523.00M | 353.00M | 562.00M | 496.00M | 609.00M | 519.00M |
| Tax | 92.00M | 52.00M | 121.00M | 158.00M | 125.00M | 71.00M |
| Net profit | 434.00M | 313.00M | 423.00M | 332.00M | 459.00M | 448.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.98 | 0.70 | 0.95 | 0.75 | 1.05 | 1.02 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 4.52B | 3.07B | 3.98B | 2.45B | 2.81B | 2.92B | 3.49B | 2.23B |
| Cash & ST investments | 2.76B | 1.32B | 2.34B | 816.00M | 1.19B | 1.26B | 1.89B | 465.00M |
| Inventory | 33.00M | 23.00M | 26.00M | 28.00M | 29.00M | 20.00M | 21.00M | 23.00M |
| Total assets | 17.02B | 17.30B | 17.88B | 22.15B | 21.71B | 18.68B | 18.44B | 17.94B |
| Total current liabilities | 2.69B | 3.22B | 2.65B | 2.58B | 4.89B | 3.23B | 3.44B | 3.47B |
| Short-term debt | 3.00M | 648.00M | 83.00M | 64.00M | 1.70B | 428.00M | 1.03B | 854.00M |
| Long-term debt | 3.21B | 2.68B | 3.77B | 3.79B | 3.11B | 2.91B | 1.85B | 1.33B |
| Total liabilities | 7,808,000,000.00 | 7,735,000,000.00 | 7,901,000,000.00 | 8,315,000,000.00 | 9,826,000,000.00 | 7,620,000,000.00 | 6,431,000,000.00 | 6,026,000,000.00 |
| Total equity | 9.21B | 9.56B | 9.98B | 13.83B | 11.89B | 11.06B | 12.01B | 11.91B |
| Retained earnings | 4.74B | 4.97B | 5.21B | 9.15B | 7.64B | 8.68B | 9.70B | 9.22B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.89B | 2.26B | 2.19B | 2.23B | 2.13B | 2.27B |
| Cash & ST investments | 1.41B | 727.00M | 705.00M | 465.00M | 489.00M | 567.00M |
| Inventory | -- | -- | -- | 23.00M | -- | -- |
| Total assets | 18.48B | 17.97B | 17.85B | 17.94B | 17.94B | 18.08B |
| Total current liabilities | 3.16B | 2.85B | 3.56B | 3.47B | 3.53B | 4.45B |
| Short-term debt | 1.03B | 561.00M | 899.00M | 854.00M | 1.12B | 1.68B |
| Long-term debt | 1.84B | 1.34B | 1.34B | 1.33B | 1.33B | 1.32B |
| Total liabilities | 6,182,000,000.00 | 5,350,000,000.00 | 6,089,000,000.00 | 6,026,000,000.00 | 6,132,000,000.00 | 6,954,000,000.00 |
| Total equity | 12.30B | 12.62B | 11.76B | 11.91B | 11.81B | 11.13B |
| Retained earnings | 9.87B | 9.93B | 9.11B | 9.22B | 9.15B | 9.05B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.06B | 702.00M | 1.75B | 1.77B | 1.92B | 2.34B | 2.46B | 2.65B |
| Depreciation & amortization | 619.00M | 717.00M | 792.00M | 770.00M | 724.00M | 725.00M | 822.00M | 930.00M |
| Free cash flow | 1.49B | 197.00M | 1.24B | 1.29B | 1.32B | 1.80B | 1.85B | 2.02B |
| Dividends paid | -903.00M | -701.00M | -732.00M | -775.00M | -837.00M | -892.00M | -949.00M | -1.04B |
| Stock buybacks / issuance | -9.96B | -488.00M | -200.00M | -1.40B | -1.28B | -3.12B | -639.00M | -1.00B |
| Ending cash balance | 2.70B | 825.00M | 1.79B | 778.00M | 1.07B | 1.30B | 1.97B | 511.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 445.00M | 746.00M | 704.00M | 756.00M | 505.00M | 920.00M |
| Depreciation & amortization | 226.00M | 230.00M | 234.00M | 240.00M | 245.00M | 253.00M |
| Free cash flow | 294.00M | 583.00M | 542.00M | 598.00M | 349.00M | 743.00M |
| Dividends paid | -260.00M | -261.00M | -261.00M | -257.00M | -281.00M | -276.00M |
| Stock buybacks / issuance | 0 | 0 | -670.00M | -330.00M | -262.00M | -705.00M |
| Ending cash balance | 1.37B | 664.00M | 618.00M | 511.00M | 400.00M | 577.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 35.74 | 16.82 | 11.59 | 48.21 | 10.47 | 23.67 | 19.30 | 12.64 |
| ROA %i | 18.13 | 9.09 | 6.37 | 28.41 | 6.09 | 13.32 | 11.88 | 8.24 |
| ROIC %i | 25.60 | 13.26 | 9.67 | 36.82 | 8.69 | 18.05 | 15.59 | 11.05 |
| 5-year avg ROE %i | 18.65 | 19.47 | 19.90 | 24.62 | 24.54 | 22.15 | 22.65 | 22.86 |
| EBIT margin %i | 15.11 | 19.95 | 32.84 | 19.77 | 34.50 | 32.75 | 30.72 | 28.32 |
| FCF / sales %i | 27.01 | 3.34 | 20.74 | 20.26 | 19.92 | 26.45 | 25.49 | 26.98 |
| Current ratioi | 1.68 | 0.95 | 1.50 | 0.95 | 0.57 | 0.90 | 1.02 | 0.64 |
| Quick ratioi | 1.54 | 0.80 | 1.34 | 0.75 | 0.48 | 0.76 | 0.89 | 0.49 |
| Debt / assetsi | 18.90 | 20.68 | 22.81 | 18.27 | 23.01 | 18.96 | 16.68 | 13.22 |
| LT debt / equityi | 35.31 | 30.99 | 40.48 | 29.02 | 27.97 | 28.43 | 17.19 | 12.86 |
| Interest coveragei | 2.79 | 5.69 | 9.78 | 6.24 | 11.21 | 9.39 | 11.09 | 11.57 |
| Revenue CAGR (3Y) %i | -21.23 | -19.13 | 4.15 | 4.89 | 3.91 | 4.32 | 4.57 | 4.10 |
| Net income CAGR (3Y) %i | 46.34 | -20.37 | -7.00 | 13.09 | -5.07 | 33.92 | -27.03 | 3.93 |
| FCF CAGR (3Y) %i | -7.65 | -54.41 | -6.33 | -4.70 | 88.53 | 13.13 | 12.89 | 15.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.50 | 13.46 | 14.83 | 12.64 | 12.63 | 13.97 |
| ROA %i | 11.57 | 8.98 | 9.66 | 8.24 | 8.36 | 9.20 |
| ROIC %i | 14.72 | 11.61 | 12.73 | 11.05 | 11.08 | 12.31 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.37 | 29.71 | 32.23 | 28.32 | 28.72 | 30.32 |
| FCF / sales %i | 25.53 | 25.79 | 24.70 | 26.98 | 27.04 | 28.50 |
| Current ratioi | 0.91 | 0.79 | 0.61 | 0.64 | 0.60 | 0.51 |
| Quick ratioi | 0.78 | 0.64 | 0.49 | 0.49 | 0.47 | 0.38 |
| Debt / assetsi | 16.57 | 11.65 | 13.54 | 13.22 | 13.64 | 17.60 |
| LT debt / equityi | 16.51 | 12.14 | 12.90 | 12.86 | 11.24 | 13.52 |
| Interest coveragei | 11.27 | 11.50 | 12.38 | 11.57 | 12.16 | 12.57 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Legal Professionals is the largest reported line at 39.51% of revenue, across 6 reported segments.
- No single line clears half of revenue; Corporates is next at 27.48%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Legal Professionals39.51%
Corporates27.48%
Tax, Audit & Accounting Professionals15.92%
Reuters11.72%
Global Print5.68%
Quote time 2026-10-08 04:00:07 · For reference only, not investment advice and not tailored to your situation.